• 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 12522 Citations
  • 37 h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Epithelial-Mesenchymal Transition Medicine & Life Sciences
Proteomics Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
DNA Repair Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

A phase I dose-escalation study of veliparib combined with carboplatin and etoposide in patients with extensive-stage small cell lung cancer and other solid tumors

Atrafi, F., Groen, H. J. M., Byers, L. A., Garralda, E., Lolkema, M. P., Sangha, R. S., Viteri, S., Chae, Y. K., Ross Camidge, D., Gabrail, N. Y., Hu, B., Tian, T., Nuthalapati, S., Hoening, E., He, L., Komarnitsky, P. & Calles, A., Jan 15 2019, In : Clinical Cancer Research. 25, 2, p. 496-505 10 p.

Research output: Contribution to journalArticle

Carboplatin
Small Cell Lung Carcinoma
Etoposide
Neoplasms
Disease Progression

Beyond chemotherapy: Emerging biomarkers and therapies as small cell lung cancer enters the immune checkpoint era

Della Corte, C. M., Gay, C. M. & Byers, L. A., Feb 15 2019, In : Cancer. 125, 4, p. 496-498 3 p.

Research output: Contribution to journalArticle

Small Cell Lung Carcinoma
Biomarkers
Drug Therapy
Therapeutics

Differential sensitivity analysis for resistant malignancies (DISARM) identifies common candidate therapies across platinum-resistant cancers

Gay, C. M., Tong, P., Cardnell, R. J., Sen, T., Su, X., Ma, J., Bara, R. O., Johnson, F. M., Wakefield, C., Heymach, J. V., Wang, J. & Byers, L. A., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 346-357 12 p.

Research output: Contribution to journalArticle

Platinum
Small Cell Lung Carcinoma
Neoplasms
Pharmaceutical Preparations
Aurora Kinase A

Evading the STING: LKB1 loss leads to STING silencing and immune escape in KRAS-mutant lung cancers

Corte, C. M. D. & Byers, L. A., Jan 1 2019, In : Cancer Discovery. 9, 1, p. 16-18 3 p.

Research output: Contribution to journalArticle

Gene Silencing
Interferons
Lung Neoplasms
Non-Small Cell Lung Carcinoma
Immunotherapy

ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer

Della Corte, C. M., Gay, C. M., Byers, L. A. & Morgillo, F., Jan 1 2019, In : EBioMedicine. 39, p. 5-6 2 p.

Research output: Contribution to journalComment/debate

Lung Neoplasms